Michael David Woodrow

Title: Michael David Woodrow: Innovator in Pharmaceutical Chemistry

Introduction

Michael David Woodrow is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of novel compounds with therapeutic applications.

Latest Patents

Among his latest patents, Woodrow has developed Tetrahydroquinoline derivatives and their pharmaceutical use. This includes Tetrahydroquinoline compounds of formula (I) and salts thereof, as well as pharmaceutical compositions containing such compounds and their use in therapy. Another significant patent involves Pyrazole derivatives used as CCR4 receptor antagonists, which encompasses Indazole compounds, processes for their preparation, intermediates usable in these processes, and pharmaceutical compositions containing such compounds and their use in therapy.

Career Highlights

Throughout his career, Woodrow has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and GlaxoSmithKline LLC. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in drug development.

Collaborations

Woodrow has collaborated with several professionals in his field, including Michael David Barker and Anthony William Dean. These collaborations have further enriched his research and development efforts.

Conclusion

Michael David Woodrow's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His innovative work continues to impact the field positively.